🚀 VC round data is live in beta, check it out!
Aroa Biosurgery Overview
About Aroa Biosurgery
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
Founded
2007
HQ
Employees
251
Website
Financials (LTM)
EV
$153M
Aroa Biosurgery Financials
Aroa Biosurgery reported last 12-month revenue of $57M and EBITDA of $4M.
In the same LTM period, Aroa Biosurgery generated $50M in gross profit, $4M in EBITDA, and $1M in net income.
Revenue (LTM)
Aroa Biosurgery P&L
In the most recent fiscal year, Aroa Biosurgery reported revenue of $54M and EBITDA of $3M.
Aroa Biosurgery expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $57M | XXX | $54M | XXX | XXX | XXX |
| Gross Profit | $50M | XXX | $46M | XXX | XXX | XXX |
| Gross Margin | 87% | XXX | 86% | XXX | XXX | XXX |
| EBITDA | $4M | XXX | $3M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | (1%) | XXX | XXX | XXX |
| Net Profit | $1M | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | 2% | XXX | (4%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Aroa Biosurgery Stock Performance
Aroa Biosurgery has current market cap of $163M, and enterprise value of $153M.
Market Cap Evolution
Aroa Biosurgery's stock price is $0.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $153M | $163M | -1.1% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAroa Biosurgery Valuation Multiples
Aroa Biosurgery trades at 2.7x EV/Revenue multiple, and 40.3x EV/EBITDA.
EV / Revenue (LTM)
Aroa Biosurgery Financial Valuation Multiples
As of March 21, 2026, Aroa Biosurgery has market cap of $163M and EV of $153M.
Equity research analysts estimate Aroa Biosurgery's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Aroa Biosurgery has a P/E ratio of 142.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $163M | XXX | $163M | XXX | XXX | XXX |
| EV (current) | $153M | XXX | $153M | XXX | XXX | XXX |
| EV/Revenue | 2.7x | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | 40.3x | XXX | 61.0x | XXX | XXX | XXX |
| EV/EBIT | 143.8x | XXX | (198.5x) | XXX | XXX | XXX |
| EV/Gross Profit | 3.1x | XXX | 3.3x | XXX | XXX | XXX |
| P/E | 142.8x | XXX | (71.7x) | XXX | XXX | XXX |
| EV/FCF | (48.6x) | XXX | (48.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Aroa Biosurgery Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Aroa Biosurgery Margins & Growth Rates
Aroa Biosurgery's revenue in the last 12 month grew by 17%.
Aroa Biosurgery's revenue per employee in the last FY averaged $0.2M.
Aroa Biosurgery's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Aroa Biosurgery's rule of X is 50% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Aroa Biosurgery Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 126% | XXX | 53% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 50% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 79% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 96% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Aroa Biosurgery Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nyxoah | XXX | XXX | XXX | XXX | XXX | XXX |
| Edap TMS | XXX | XXX | XXX | XXX | XXX | XXX |
| Inogen | XXX | XXX | XXX | XXX | XXX | XXX |
| Pro-Dex | XXX | XXX | XXX | XXX | XXX | XXX |
| AVITA Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Aroa Biosurgery M&A Activity
Aroa Biosurgery acquired XXX companies to date.
Last acquisition by Aroa Biosurgery was on XXXXXXXX, XXXXX. Aroa Biosurgery acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Aroa Biosurgery
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAroa Biosurgery Investment Activity
Aroa Biosurgery invested in XXX companies to date.
Aroa Biosurgery made its latest investment on XXXXXXXX, XXXXX. Aroa Biosurgery invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Aroa Biosurgery
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Aroa Biosurgery
| When was Aroa Biosurgery founded? | Aroa Biosurgery was founded in 2007. |
| Where is Aroa Biosurgery headquartered? | Aroa Biosurgery is headquartered in United States. |
| How many employees does Aroa Biosurgery have? | As of today, Aroa Biosurgery has over 251 employees. |
| Is Aroa Biosurgery publicly listed? | Yes, Aroa Biosurgery is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Aroa Biosurgery? | Aroa Biosurgery trades under ARX ticker. |
| When did Aroa Biosurgery go public? | Aroa Biosurgery went public in 2020. |
| Who are competitors of Aroa Biosurgery? | Aroa Biosurgery main competitors are Nyxoah, Edap TMS, Inogen, Pro-Dex. |
| What is the current market cap of Aroa Biosurgery? | Aroa Biosurgery's current market cap is $163M. |
| What is the current revenue of Aroa Biosurgery? | Aroa Biosurgery's last 12 months revenue is $57M. |
| What is the current revenue growth of Aroa Biosurgery? | Aroa Biosurgery revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of Aroa Biosurgery? | Current revenue multiple of Aroa Biosurgery is 2.7x. |
| Is Aroa Biosurgery profitable? | Yes, Aroa Biosurgery is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Aroa Biosurgery? | Aroa Biosurgery's last 12 months EBITDA is $4M. |
| What is Aroa Biosurgery's EBITDA margin? | Aroa Biosurgery's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Aroa Biosurgery? | Current EBITDA multiple of Aroa Biosurgery is 40.3x. |
| What is the current FCF of Aroa Biosurgery? | Aroa Biosurgery's last 12 months FCF is ($3M). |
| What is Aroa Biosurgery's FCF margin? | Aroa Biosurgery's last 12 months FCF margin is (6%). |
| What is the current EV/FCF multiple of Aroa Biosurgery? | Current FCF multiple of Aroa Biosurgery is (48.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.